Juvenescence onboards Dr Richard Marshall CBE as CEO
Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as Executive Chairman. Dr Marshall brings over twenty years of business leadership to the company, with fifteen years at GSK culminating in his position as Vice […]
Morphoceuticals showcase successful limb regeneration in frogs
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xenopus laevis (African clawed frog). This is said to be the first demonstration of functional limb regeneration in a species that does not show spontaneous regeneration […]